Kiltearn Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Kiltearn Partners's MDT Position: Q3 2026 in Review
Kiltearn Partners reduced its Medtronic (MDT) stake by 4% in Q3 2026, selling an estimated $509K and leaving 137,008 shares worth $11.8M. The position accounts for 2.85% of the portfolio, ranked #13.
Kiltearn Partners first reported a position in MDT in Q4 2022 and has held it in 16 quarters since. The position peaked at $32.6M in Q4 2023. 2,189 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Kiltearn Partners held 137,008 shares of Medtronic worth $11.8M as of Q3 2026.
- Kiltearn Partners sold 5,780 Medtronic shares in Q3 2026, an estimated $509K.
- Medtronic made up 2.85% of Kiltearn Partners's portfolio in Q3 2026, its #13 holding.
- Kiltearn Partners first reported a position in Medtronic in Q4 2022 and has held it in 16 quarters since.
- Kiltearn Partners's Medtronic position peaked at $32.6M in Q4 2023.
- 2,189 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Kiltearn Partners's 13F filing for Q3 2026, filed 13 Nov 2026.